SINOMAB BIO-B: Notification Letter to Non-registered Shareholders and Reply Form
Apr 26 04:51 ET
SINOMAB BIO-B: Notification Letter to Registered Shareholders and Reply Form
Apr 26 04:50 ET
SINOMAB BIO-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 6, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON FRIDAY, 14 JUNE 2024 AT 10:00 A.M.
Apr 26 04:48 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 06:34 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 03:53 ET
SINOMAB BIO-B: Letter to Non-Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
Feb 8 23:12 ET
SINOMAB BIO-B: Letter to Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
Feb 8 23:08 ET
SINOMAB BIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Feb 7 04:52 ET
SINOMAB BIO-B: APPOINTMENT OF EXECUTIVE DIRECTOR
Feb 7 04:49 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 03:36 ET
SINOMAB BIO-B: Next Day Disclosure Return
Jan 31 09:25 ET
SINOMAB BIO-B: Next Day Disclosure Return
Jan 12 07:02 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 4 03:49 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 5, 2023 03:31 ET
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT FIRST COHORT OF THE HEALTHY SUBJECTS DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN CHINA
Nov 27, 2023 08:07 ET
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM03 (SUCIRASLIMAB) FOR THE TREATMENT OF ALZHEIMER''S DISEASE ACCEPTED BY NMPA CDE
Nov 15, 2023 06:51 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Nov 2, 2023 04:36 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Oct 4, 2023 04:33 ET
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SM17 BY NMPA
Sep 11, 2023 06:42 ET
SINOMAB BIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Sep 6, 2023 04:44 ET
No Data
No Data